BCRX — BioCryst Pharmaceuticals, Inc. stock price, charts and financials

QT48BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.68
-0.02-0.23%
OverviewShort InterestFilings
BCRXQT48BioCryst Pharmaceuticals, Inc.·NASDAQ
8.68-0.23%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 2026S-8Registration of employee benefit securities
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Aug 04, 20268-K/ACurrent report (amended)
Jun 29, 20268-KCurrent report
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 400
Page
▼
/ 16